ѻýҕl

Eating Disorder Spike; $1M Fraud at Psych Clinic? Risperidone LAI Heads Back to FDA

<ѻýҕl class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

After the start of the COVID-19 pandemic, there was a 7.2% increase in each month among adolescents and young adults, lasting through April 2021. (JAMA Pediatrics)

People with a history of saw a much higher incidence of subsequent physical health conditions as well as significant loss of life years. "These findings strongly suggest that clinical vigilance and high-quality integrated treatment for people with substance use disorders could be life-saving and should be given higher priority on the public health agenda," researchers wrote in The Lancet Psychiatry.

in outpatient lab work was associated with a subsequent eating disorder diagnosis anywhere from 30 days to 3 years later. (JAMA Network Open)

A Pennsylvania-based psychiatric practice allegedly billed Medicare for as part of a $1 million fraud scheme. (Lehigh Valley Live)

In partnership with MedinCell, Teva Pharmaceuticals announced the FDA new drug application resubmission for its long-acting injection risperidone (mdc-IRM) for schizophrenia. The resubmission comes after the FDA hit the developer with a complete response letter back in April, requesting a clinical data quality check.

According to data on over 11 million U.K. patients with a plus a prescription for a related pharmacological treatment, there was a significantly increased risk seen not just for severe COVID infection, but also for other severe acute respiratory infections. (JAMA Psychiatry)

Hear how one woman from England explained how her bipolar disorder-related psychosis led her to believe . (New York Post)

Psychosocial prevention programs helped to significantly cut down on experiences of , a 20-trial meta-analysis found. (JAMA Network Open)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.